Securities Class Action Targets Inspire Medical Over Inspire V Launch as Deadline Notices Clash

Plaintiff firms are recruiting lead‑plaintiff candidates, with notices listing conflicting filing dates that require court confirmation.

Overview

In the U.S. District Court for the District of Minnesota, City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247, alleges Securities Exchange Act violations.
The putative class covers purchasers of Inspire Medical common stock from August 6, 2024 through August 4, 2025, inclusive.
The complaint claims investors were misled about the Inspire V rollout, citing poor demand, surplus provider inventory, incomplete center onboarding, and delayed billing software updates.
On August 4, 2025, the company disclosed an “elongated timeframe” for Inspire V, cut 2025 guidance by more than 80%, and saw its shares fall by over 32%, according to the filing.
Robbins Geller and Robbins LLP list January 5, 2026 for lead‑plaintiff motions, while the Portnoy Law Firm lists January 5, 2025, highlighting a procedural discrepancy; the allegations remain unproven.